Dr. Kevin Zorn Bio
Dr. Kevin Zorn is board-certified in both the U.S. and Canada in minimally-invasive uro-oncology. He completed his fellowship in urology at the University of Chicago. His main focus of clinical and scientific interest is in the surgical treatment of renal and prostate cancer. He is also an expert in performing surgery with the DaVinci Surgical Robotic System which is used to manage localized prostate cancer and small renal masses. Dr. Zorn is the most experienced robotic surgeon in Canada having performed over 1,500 DaVinci procedures. He is currently the Director of Robotic Surgery at the Centre hospitalier de l’Université de Montréal (CHUM). Dr. Zorn is also the national Canadian surgical trainer and proctor for the Greenlight XPS 180W laser which is used for the minimally-invasive treatment of benign prostatic hyperplasia. Dr. Zorn’s other research interests include surgical, cancer-control and quality-of-life outcomes after radical prostatectomy for prostate cancer. He has published extensively in this subject with over 155 peer-reviewed papers and eight book chapters. He has received awards for his clinical work, research and teaching from the Endourological Society. He is also a reviewer for many urological journals and has been awarded Best Reviewer for Prostate Cancer in 2009 and 2010 for the Journal of Urology. He is also a member of the American Urological Association (AUA) educational task force for the development of the laparoscopic and robotic urologic surgery curriculum and continues to be the AUA hands-on course director for the annual AUA annual meetings. In 2010, Dr. Zorn returned home to Montreal to develop the robotic urological program at the CHUM where he serves as Assistant Professor of Surgery and Director of Robotic Surgery. His current practice is focused on minimally invasive robotic and laser surgery for prostate pathology. He also performs laparoscopic surgery for renal and adrenal tumors. Dr. Zorn also performs no-needle, no-scalpel, single micro-assess vasectomy for his patients. He is active in the minimally-invasive (MIS) urology program focusing on resident hands-on simulation and training at the Université de Montréal. Not only has Dr. Zorn helped with the national AUA (American Urological Association) and CUA (Canadian Urological Association) BPH guidelines, he is also an active with various other minimally invasive therapies with Urolift, Rezum, Aquablation and other cutting edge technologies. Doctor Zorn offers all these minimally invasive BPH therapies at SanoMed clinic in the Brunswick Medical Center in Montreal. For more information on the REZUM procedure, please click the following link: Sanomed Urology Dr. Zorn is the senior author of the Male LUTS/BPH guidelines for the 2018 and 2022 Canadian Urological Association and has been an invited reviewer of the American Urological Association BPH guidelines. He has also helped create national online programs in robotic prostate cancer care and rehabilitation as well as a BPH patient decision aid tool. Over the past 17 years, he has now authored 345 peer-reviewed publications and 12 book chapters on BPH and minimally invasive surgical care. With such accolades, Dr. Zorn has become a sought-after speaker, teacher and researcher. He has travelled to lecture, teach and proctor surgery around the world, and is intimately involved with the development of several new, pioneering BPH technologies. Education & Training Dr. Zorn attended McGill University for his pre-med Bachelor program, then completed his medical degree followed by residency in urological surgery at McGill. He became a fellow of the Royal College of Physicians and Surgeons of Canada in 2005. He has completed a two-year fellowship in oncology and endourology at the University of Chicago. Dr. Zorn also became American Board of Urology certified in urology and a fellow of the American College of Surgeons. After remaining on faculty at the University of Chicago until 2009, Dr. Zorn returned to Canada in 2010 to join the faculty of the Division of Urology at the University of Montreal. Career Achievements As an attending urologist, he has cultivated a clinical and research interest in localised prostate cancer, robotic surgery (over 3500 robotic prostatectomy cases performed), artificial intelligence, men’s health, sexual dysfunction and BPH. He holds a number of roles including medical director of robotic surgery and fellowship director for robotics and MIS since 2011. He is also the founder of intuitiveurology.com (a global platform for resident urological education materials and self-testing) as well as BPHCanada.com. In summary, Dr. Zorn is a world-renowned surgeon scientist in the field of urology who continues to make significant contributions to urological education, research and clinical BPH services.
Dr. Kevin Zorn , urologist Montreal Is in good standing with the College of Physicians and Surgeons of Canada,Dr. Kevin Zorn , urologist Montreal is in good standing with the Canadian Urological Society and the Canadian Medical Association
Keywords: Cancer: BPH, Cancer: Prostate Nutrition, Cancer: Breast Cancer, Cancer: Colon and Rectal Cancer Cancer: Lung Cancer, Cancer: Melanoma, Cancer: Ovarian Cancer, Cancer: Prostate Cancer
Dr. Kevin Zorn , urologist Montreal
Video by Dr kevin Zorn
Medication side effects and lifestyle treatment options
Diagnosing the Stage and Grade of Prostate Cancer
BPH and the Cystoscopy Procedure
BPH - Treatment with Medications
( Dr. Kevin Zorn, Urologist, Montreal, QC) is in good standing with the College of Physicians and Surgeons.
If you are looking for local services or treatment froma local urologist in the office or hospital from a Urologist, contact a provider such as ( Dr. Kevin Zorn ) to inquire if they are accepting patients or you need a referral. Phone number to book an appointment PHONE = 514-443-0808 ( Dr. Kevin Zorn ) Is in good standing with the College of Physicians and Surgeons ( Dr. Kevin Zorn ) Is in good standing with the Canadian Urological Society ( Dr. Kevin Zorn ) Is in good standing with the Canadian Medical Association
Keywords: Cancer: BPH, Cancer: Prostate Nutrition, Cancer: Breast Cancer, Cancer: Colon and Rectal Cancer Cancer: Lung Cancer, Cancer: Melanoma, Cancer: Ovarian Cancer, Cancer: Prostate Cancer
The speaker in the video may have no association with ( Dr. Kevin Zorn, Urologist Montreal, QC ).
( Dr. Kevin Zorn, Urologist Montreal, QC ), may talk about some of the conditions and some of the treatment options shown on the videos. Always talk with your Local Urologist about the information you learnt from the videos in regards to Male incontinence Contino® treatments and procedures the Local Urologist could perform and if they would be appropriate for you. Remember good information from your Local Urologist is the corner stone to understanding your condition or disease.
Health Talks:
Sexual preservation for BPH prostate surgery
Urology Practice isa great pleace to start to look into If you’re experiencing symptoms of male incontinence, a local urologist can help. A local urologist can ask about your symptoms and recommend further testing or male incontinence treatment. Urethral inserts like Contino® are temporarily inserted into the urethra (the tube which carries urine to the outside of the body) to prevent or reduce bladder leakage. Damage to the kidneys can lead to swelling in the hands and ankles, high blood pressure, and other symptoms.
Please contact ( Dr. Kevin Zorn, Urologist Montreal, QC ) to enquire if this health care provider is accepting new patients. Prostate Cancer NOW is part of the Now Health Network and its focus is on muscular and skeletal conditions. In summary, there are many different treatments for prostate cancer. Identifying the best treatment will depend on your specific situation and your preference after discussion with your doctor. It is not true Asian men have the lowest risk of developing prostate cancer. African men have the highest risk. Often seeing a local urologist in Toronto can help.
Medications like alpha blockers don't actually treat BPH, they treat the symptoms by relaxing the muscle around the urethra, so thereby reducing some of the resistance.
Sometimes we will add in a second line medication in order to try and shrink the prostate. These medications are called the five alpha reductase inhibitors. So we have Proscar or Avodart These are medications which work by lowering the conversion of testosterone within the prostate. Over a period of 6 to 12 months, this can shrink the prostate by around 20%.
Education
Related Topics
Recent Health Talks Authored by Dr. Kevin Zorn
Recent Health Talk Comments by Dr. Kevin Zorn
Ratings for Dr. Kevin Zorn
– Take a look at your local options in Montreal
If you are the practitioner featured on this page and would like to either update the current information or claim the page please take advantage of our patient and physician resources here.
If on the other hand you would like to be removed for whatever reason from the directory please click here.
This content is for informational purposes only, and is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare professional with any questions you may have regarding a medical condition.
James is a 78-year-old retired psychologist with three children. Although he remains active and physically fit, he has been experiencing urinary troubles progressively for the past 3 years. He presented to his family medicine MD to be evaluated and had otherwise normal blood work. After being told he may have an enlarged prostate, he was initiated on Flomax medication to relax the prostate. The relief was minimal and James continued to have a markedly slow stream and continued to wake up 2-3 times per night. He was offered other medications to potentially shrink the prostate (Proscar) however being still sexually active, he did not want some of the potential side effects of these prostate medications, notably a reduced libido and ejaculatory dysfunction. As such, James was referred to see a urologist.
Upon urology consultation, non-invasive studies were conducted to objectively assess the urinary flow rate (Uroflowmetry) and ultrasounds to assess the residual urine volume in the bladder along with the prostate size/volume/dimensions. Since medications were no longer an option for the enlarged prostate, surgical treatments were discussed. While there were several to consider, from the gold standard technique of TURP to office based, minimally invasive procedures (including iTind and REZUM), James was most impressed with the most advanced technique of Aquablation.
Aquablation has the unique merger of ultrasound imaging to help personalize and customize the treatment contour. After creating a real-time map of the treatment prostate area, the robot system utilizes high pressure water to ablate obstructive prostate tissue. Furthermore, such a precise treatment of BPH helps preserve critical apical anatomy to conserve full urinary continence and ejaculation. These were most important for him to remain physically active and continue with his sexual life.
Now 4 weeks following his Aquablation, James is relieved of all of his obstructive lower urinary tract symptoms and no longer continues on any medications. He has full erections and unchanged ejaculation functions. James is now an advocate that sexual parameters are essential to be discussed for BPH (benign prostate hyperplasia) enlarged prostate discussions. All so often overlooked, most men globally are receiving TURP for the BPH surgery with >80% likelihood loss of ejaculation from such surgery.